Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Italy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Israel < Italy < Itraconazole  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000726 (2018) F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie]Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
000864 (2018) Dario Camellino [Italie] ; Stefano Soldano [Italie] ; Maurizio Cutolo [Italie] ; Marco A. Cimmino [Italie]Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition.
000A30 (2017) Giovanna Cuomo [Italie] ; Virginia D Brosca [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie]The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
000B55 (2017) Sara Monti [Italie] ; Catherine Klersy [Italie] ; Roberto Gorla [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Pellerito [Italie] ; Enrico Fusaro [Italie] ; Giuseppe Paolazzi [Italie] ; Pier Andrea Rocchetta [Italie] ; Ennio Giulio Favalli [Italie] ; Antonio Marchesoni [Italie] ; Roberto Caporali [Italie]Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
001005 (2015) M. Ollé [Espagne]The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy).
001098 (2015) Gian Luca Erre [Italie] ; Giuseppe Mameli [Italie] ; Davide Cossu [Italie] ; Benedetta Muzzeddu [Italie] ; Cristina Piras [Italie] ; Daniela Paccagnini [Italie] ; Giuseppe Passiu [Italie] ; Leonardo Antonio Sechi [Italie]Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
001459 (2013) Enrico Tombetti [Italie] ; Stefano Franchini ; Maurizio Papa ; Maria Grazia Sabbadini ; Elena BaldisseraTreatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
001779 (2012) Alexander Diamantopoulos [Royaume-Uni] ; Maurizio Benucci ; Stefano Capri ; Wolfgang Berger ; Neil Wintfeld ; Giovanni Giuliani ; Walter RicciardiEconomic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.
001909 (2011) G. Lapadula [Italie] ; G. Ferraccioli ; C. Ferri ; L. Punzi ; F. TrottaGISEA: an Italian biological agents registry in rheumatology.
001C37 (????) -. Lombardy Section Italian Society Infectious And Tropical DiseasesVademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.
001C66 (????) Sergio Iannazzo [Italie] ; Maurizio Benucci [Italie] ; Ennio Giulio Favalli [Italie]Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
001D26 (????) Roberta Gualtierotti [Italie] ; Francesca Ingegnoli [Italie] ; Samantha Griffini [Italie] ; Elena Grovetti [Italie] ; Pier Luigi Meroni [Italie] ; Massimo Cugno [Italie]Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
001D27 (????) Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.
001D37 (????) Chiara Bazzani [Italie] ; Rossana Scrivo [Italie] ; Laura Andreoli [Italie] ; Elena Baldissera [Italie] ; Martina Biggioggero [Italie] ; Valentina Canti [Italie] ; Maria Gerosa [Italie] ; Irene Pontikaki [Italie] ; Véronique Ramoni [Italie] ; Laura Trespidi [Italie] ; Sonia Zatti [Italie] ; Roberto Caporali [Italie] ; Roberto Gorla [Italie] ; Florenzo Iannone [Italie] ; Andrea Lojacono [Italie] ; Pierluigi Meroni [Italie] ; Carlomaurizio Montecucco [Italie] ; Mario Motta [Italie] ; Maria Grazia Sabbadini [Italie] ; Guido Valesini [Italie] ; Angela Tincani [Italie]Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study.
001D69 (????) Olga Addimanda [Italie] ; Niccol Possemato ; Pierluigi Macchioni ; Carlo SalvaraniEfficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Italy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Italy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Italy
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021